A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma

Clinical trial NCT07010120 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07010120
Sponsor: West China Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HNSCC Lysogenic HSV Virus Neoadjuvant Therapy Immunotherapy Targeted Therapy

Start date: 2025-06-10
Primary completion: 2027-05-31
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.